NEWSALY™
    A World Of News, One Window.Friday, November 20, 2026
    Search
    Videos
    world

    Vacina experimental contra câncer reduz em 41% risco de morte de pacientes com leucemia mieloide aguda

    G1
    November 20, 2026
    via G1

    You're reading one story from Newsaly

    Newsaly brings together 60,000+ newspaper articles, 30,000+ podcasts and 10,000+ magazine articles from around the world.

    A World Of News, One Window.

    Explore Today's News
    Vacina experimental contra câncer reduz em 41% risco de morte de pacientes com leucemia mieloide aguda

    Ações da Moderna disparam 90% após vacina personalizada contra câncer ter teste positivo Uma vacina experimental aumentou em cerca de nove meses a sobrevida de pacientes com leucemia mieloide aguda (LMA), um dos cânceres do sangue mais agressivos. Entre os vacinados, a sobrevida mediana foi de 24 me

    Read the full story

    Explore More On Newsaly

    60,000+ Newspaper Articles

    Explore newspapers from around the world.

    Explore Newspapers

    30,000+ Podcasts

    Discover podcasts and listen to the latest conversations and news.

    Explore Podcasts

    10,000+ Magazine Articles

    Explore magazine articles from around the world.

    Explore Magazines

    Voices (0)

    Share a 15-second voice reaction. Voices automatically disappear after 10 days.

    Sign in to record a voice on this article.

    Be the first to share a voice on this article.